Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels

Indacochea Cusirramos, Alberto; Guerrero Jijon, Santiago Xavier; Ureña, Macarena; Araujo, Ferrán; Coll, Olga; Lleonart, Matilde E.; Gebauer, Fátima

doi:http://dx.doi.org/ 10.1261/rna.076422.120

Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels

License

Citation

Indaochea A, Guerrero S, Ureña M, Araujo F, Coll O, Lleonart MA et al. Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels. RNA. 2021 Feb;27(2):190-201. DOI: 10.1261/rna.076422.120

Abstract

Cold-inducible RNA binding protein (CIRBP) is a stress-responsive protein that promotes cancer development and inflammation. Critical to most CIRBP functions is its capacity to bind and posttranscriptionally modulate mRNA. However, a transcriptome-wide analysis of CIRBP mRNA targets in cancer has not yet been performed. Here, we use an ex vivo breast cancer model to identify CIRBP targets and mechanisms. We find that CIRBP transcript levels correlate with breast cancer subtype and are an indicator of luminal A/B prognosis. Accordingly, overexpression of CIRBP in nontumoral MCF-10A cells promotes cell growth and clonogenicity, while depletion of CIRBP from luminal A MCF-7 cells has opposite effects. We use RNA immunoprecipitation followed by high-throughput sequencing (RIP-seq) to identify a set of 204 high confident CIRBP targets in MCF-7 cells. About 10% of these showed complementary changes after CIRBP manipulation in MCF-10A and MCF-7 cells, and were highly interconnected with known breast cancer genes. To test the potential of CIRBP-mediated regulation of these targets in breast cancer development, we focused on Cystatin C (CST3), one of the most highly interconnected genes, encoding a protein that displays tumor suppressive capacities. CST3 depletion restored the effects of CIRBP depletion in MCF-7 cells, indicating that CIRBP functions, at least in part, by down-regulating CST3 levels. Our data provide a resource of CIRBP targets in breast cancer, and identify CST3 as a novel downstream mediator of CIRBP function.